ClinicalTrials.gg
Sign In

Drug

STA 9090 clinical trials

Also written STA-9090 and Ganetespib.

studies test it
37
open now
1
in phase 3
1
first study started
2007

Keep track of what changes. Save the STA 9090 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Hsp90 inhibitor STA-9090
5
STA-9090 (ganetespib)
2

Development codes

STA-9090
22

Other names

Ganetespib
22

Combined with it in one product

capecitabine + ganetespib
1
Ganetespib
1
STA-9090
1
STA9090 with Dutasteride
1
Avodart
1

Studies by the year they started

37 studies that test it; most in 2010 (9)

Studies that test STA 9090, by start year
YearStudies
20072
20093
20109
20115
20126
20134
20145
20151
20161
20181

By phase

A phase 1/2 study counts in both.

Phase 1
19
Phase 2
22
Phase 3
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Triple Negative Breast Neoplasms
3
Neoplasms
3
Breast Neoplasms
2
Lung Neoplasms
2
Small Cell Lung Carcinoma
2
Melanoma
2
Prostatic Neoplasms
2
Rectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Esophageal Neoplasms
1

Who runs them

Industry 10 · Other 27

Synta Pharmaceuticals Corp. (10) · Memorial Sloan Kettering Cancer Center (4) · Dana-Farber Cancer Institute (3) · Emory University (3) · Massachusetts General Hospital (2) · Universitaire Ziekenhuizen KU Leuven (1) · University College, London (1) · M.D. Anderson Cancer Center (1)

Often tested with

Tested in the same studies.

Paclitaxel (5) · Trastuzumab (2) · Pertuzumab (2) · Carboplatin (1) · Sirolimus (1) · Capecitabine (1) · Bortezomib (1) · Plerixafor (1)

Studies

Open first, then newest update. How each study uses STA 9090 is read from its arms, and is right about nine times in ten.

Testing it · 37

See all 37 studies that test STA 9090 →